Atlas Trials

Lymphoma, NK-cell

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphoma, NK-cell

RecordFirmDate
A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms (NCT01309789)Seagen Inc.2011-02-01

Track Lymphoma, NK-cell automatically

Every clearance here is in the API, with alerts when new ones post.